Back to Pennsylvania

HB1945 • 2025

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose response immunity.

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose response immunity.

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
FRIEL
Last action
2026-04-27
Official status
Laid on the table, April 27, 2026
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose response immunity.

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose response immunity.

What This Bill Does

  • An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose response immunity.

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

  1. 2026-04-27 JUDICIARY

    Reported as committed, April 27, 2026

  2. 2026-04-27 H

    First consideration, April 27, 2026

  3. 2026-04-27 H

    Laid on the table, April 27, 2026

  4. 2025-10-16 JUDICIARY

    Referred to JUDICIARY, Oct. 16, 2025

Official Summary Text

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose response immunity.

Current Bill Text

Read the full stored bill text
PRINTER'S NO. 2454
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE BILL
No. 1945
Session of
2025
INTRODUCED BY FRIEL, KINKEAD, WAXMAN, KHAN, GAYDOS, HOWARD,
HILL-EVANS, HANBIDGE, MAYES, SANCHEZ, INGLIS, D. WILLIAMS AND
NEILSON, OCTOBER 14, 2025
REFERRED TO COMMITTEE ON JUDICIARY, OCTOBER 16, 2025
AN ACT
Amending the act of April 14, 1972 (P.L.233, No.64), entitled
"An act relating to the manufacture, sale and possession of
controlled substances, other drugs, devices and cosmetics;
conferring powers on the courts and the secretary and
Department of Health, and a newly created Pennsylvania Drug,
Device and Cosmetic Board; establishing schedules of
controlled substances; providing penalties; requiring
registration of persons engaged in the drug trade and for the
revocation or suspension of certain licenses and
registrations; and repealing an act," further providing for
drug overdose response immunity.
The General Assembly of the Commonwealth of Pennsylvania
hereby enacts as follows:
Section 1. Section 13.7(b) of the act of April 14, 1972
(P.L.233, No.64), known as The Controlled Substance, Drug,
Device and Cosmetic Act, is amended to read:
Section 13.7. Drug Overdose Response Immunity.--* * *
(b) (1) The prohibition on charging or prosecuting a person
as described in subsection (a) bars charging or prosecuting a
person for probation and parole violations and for violations of
section 13(a)(5), (16), (19), (31), (32), (33) and (37).
(2) A person as described in subsection (a) may not be
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
charged or prosecuted for an offense under 18 Pa.C.S. § 2705
(relating to recklessly endangering another person).
* * *
Section 2. This act shall take effect in 60 days.
20250HB1945PN2454 - 2 -
1
2
3
4